Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects | Zendy

W. P. T. James | Zendy; Ian D. Caterson | Zendy; Walmir Coutinho | Zendy; Nick Finer | Zendy; Luc F. Van Gaal | Zendy; Aldo P. Maggioni | Zendy; Christian TorpPedersen | Zendy; Arya M. Sharma | Zendy; Gillian Shepherd | Zendy; Richard A. Rode | Zendy; Cheryl Renz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

Author(s) -

W. P. T. James,

Ian D. Caterson,

Walmir Coutinho,

Nick Finer,

Luc F. Van Gaal,

Aldo P. Maggioni,

Christian TorpPedersen,

Arya M. Sharma,

Gillian Shepherd,

Richard A. Rode,

Cheryl Renz

Publication year - 2010

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1003114

Subject(s) - sibutramine , medicine , hazard ratio , weight loss , overweight , placebo , stroke (engine) , blood pressure , myocardial infarction , clinical endpoint , confidence interval , randomization , diabetes mellitus , randomized controlled trial , obesity , endocrinology , mechanical engineering , alternative medicine , pathology , engineering

The long-term effects of sibutramine treatment on the rates of cardiovascular events and cardiovascular death among subjects at high cardiovascular risk have not been established.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research